Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2004

Content (13 Articles)

BAG-1 Expression Correlates with Bcl-2, p53, Differentiation, Estrogen and Progesterone Receptors in Invasive Breast Carcinoma

Shou-Ching Tang, Jessalyn Beck, Sean Murphy, Garry Chernenko, Desmond Robb, Peter Watson, Mahmoud Khalifa

Her-2/neu Gene Amplification and Protein Expression in Primary Male Breast Cancer

Christian Rudlowski, Nicolaus Friedrichs, Andree Faridi, Lazlo Füzesi, Roland Moll, Gunther Bastert, Werner Rath, Reinhard Büttner

Estrogen Disrupts Chemokine-Mediated Chemokine Release from Mammary Cells: Implications for the Interplay between Estrogen and IP-10 in the Regulation of Mammary Tumor Formation

S.M. Aronica, P. Fanti, K. Kaminskaya, K. Gibbs, L. Raiber, M. Nazareth, R. Bucelli, M. Mineo, K. Grzybek, M. Kumin, K. Poppenberg, C. Schwach, K. Janis

CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia

Bernd C. Schmid, Margarethe Rudas, Günther A. Rezniczek, Sepp Leodolter, Robert Zeillinger

Perillyl Alcohol Inhibits Human Breast Cancer Cell Growth in vitro and in vivo

Takashi Yuri, Naoyuki Danbara, Miki Tsujita-Kyutoku, Yasuhiko Kiyozuka, Hideto Senzaki, Nobuaki Shikata, Hideharu Kanzaki, Airo Tsubura

Authors Index

Author Index, Volume 84

Volume Contents

Subject Index, Volume 84

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine